Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

INvestigating Transmission and Early Replication of Rift valley fever viruS following mosquito Exposure in Cutaneous Tissue

Project description

A closer look at early RVFV infection

Rift Valley fever virus (RVFV) is a mosquito-borne virus that has spread from Africa to Europe. A threat to humans and livestock, the virus’ spread is raising concerns about future outbreaks. Supported by the Marie Skłodowska-Curie Actions programme, the INTERSECT project studies how the virus establishes infection in the skin immediately after a mosquito bite. Using 3D imaging, spatial transcriptomics, and virus-mapping techniques, it will show how RVFV replicates and interacts with the host’s immune system. The findings are likely to pave the way for the development of better therapies, vaccines, and outbreak prevention strategies.

Objective

Vector-borne viruses (arboviruses) pose an increasing global threat, causing widespread disease in both humans and animals with significant health and economic impacts. In Europe, the mosquito-borne Rift Valley Fever Virus (RVFV) is especially concerning as this virus is expanding its territory beyond Africa, causing severe disease in both humans and ruminants. Despite ongoing research, critical gaps remain in understanding the RVFV infection cycle, particularly regarding the initial mechanism of mosquito mediated transmission. Supported by the Marie Skodowska-Curie Actions program, the INTERSECT project will expand knowledge on early RVFV infection in the skin using advanced virus particle analysis and 3D imaging techniques. These insights are crucial for developing targeted therapeutics and improve risk models.
The INTERSECT project aims to investigate early RVFV infection in the skin of its natural host, focusing on mosquito transmission and replication. The specific objectives are to 1) map the genomic composition and distribution of RVFV virions, 2) examine the initial infection in ruminant skin, and 3) elucidate the early host immune response. To address its aims, the project will analyze RVFV infected mosquitos, skin biopsies and sera from infected lambs to study RVFV transmission, replication dynamics, and host immune responses. The project will employ cutting-edge methodologies, including tissue optical clearing, fluorescence in situ hybridization (FISH), advanced microscopy, and spatial transcriptomics to uncover critical insights into early RVFV infection mechanisms.
The project will provide advanced training in imaging and genomic analysis and enhance transferable skills through publications, presentations, and public engagement. INTERSECT will advance the scientific understanding of RVFV infection and develop methods applicable to other arboviruses, ultimately contributing to global health, informing vaccine development and outbreak prevention.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

STICHTING WAGENINGEN RESEARCH
Net EU contribution
€ 217 076,16
Address
DROEVENDAALSESTEEG 4
6708 PB Wageningen
Netherlands
Region
Oost-Nederland Gelderland Veluwe
Activity type
Research Organisations
Links
Total cost
No data